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DOI: 10.1039/c2md00251eSince the discovery of penicillin, bacteria have counteracted the action of antibiotics leading to
a worrisome situation about antibiotic efficiency. During our research on non-traditional 1,3-bridged
b-lactams embedded into macrocycles as potential inhibitors of Penicillin Binding Proteins (PBPs), we
unexpectedly synthesized bis-2-oxoazetidinyl macrocycles arising from a dimerization reaction under
ring closing metathesis (RCM) conditions. These molecules were revealed to be good inhibitors of the
D,D-peptidase from Actinomadura R39, which is commonly used as a model of PBPs. To pursue the
research on this type of novel compounds, a complete family of cyclodimers 4 and 5 was synthesized
and evaluated against R39, and high molecular weight D,D-peptidases: PBP2a of methicillin-resistant
Staphylococcus aureus and PBP5 of resistant Enterococcus faecium. Some bis-2-oxoazetidinyl
macrocycles exhibited very promising activities against PBP2a. In order to explain the biological
results, docking experiments of one cyclodimer (5e) into the R39 and PBP2a crystallographic structures
were performed. The 3D structures of all the dimers were studied by quantum chemistry calculations
and the reactivity of one cyclodimer (5e) was evaluated using an elaborate model of the R39 active site.
Our results highlighted that the activity of the compounds is most probably related to their
conformational adaptability, depending on the size of the macrocycles and the geometrical constraints
induced by intramolecular H bonds.Introduction
The introduction of penicillins (i.e. the b-lactam antibiotics) into
the health care system is one of the most important contributions
to medical science in the 20th century. However a consequence of
the high use of antibiotics is the emergence of resistant bacteria.
The mechanical strength of the bacterial cell wall is conferred by
an essential cross-linked biopolymer, the final step of biosyn-
thesis of which is the transpeptidation of peptidoglycan strands
catalyzed by D,D-peptidase enzymes. b-Lactam antibiotics, by
inhibiting these D,D-peptidases, also called penicillin-bindingaInstitute of Condensed Matter and Nanosciences (IMCN), Molecules,
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This journal is ª The Royal Society of Chemistry 2011proteins (PBPs), disable the normal cross-linking of peptido-
glycan and leave the bacteria sensitive to cell lysis.1 Structural
modification of the original PBPs2 is one of the mechanisms of
bacterial resistance1 and a major example of such a phenomenon
is the methicillin-resistant Staphylococcus aureus (MRSA). In
this pathogen, responsible for nosocomial infections in hospitals,
the resistance to b-lactam antibiotics is conferred by the
expression of a novel PBP with very low b-lactam affinity, named
PBP2a.3 To face the growing resistance towards existing b-lac-
tam antibiotics, the development of new compounds is required.
Recently, in the course of our research on non-traditional b-
lactams (i.e. 2-azetidinones) as potential inhibitors of PBPs, we
attempted to synthesize large ring 1,3-bridged 2-azetidinones B
via ring-closing metathesis (RCM) of precursors A as the key-
step for macrocyclization.4 However, we observed that a cyclo-
dimerization giving the bis-2-oxoazetidinyl macrocycles C was
the preferred outcome; the desired cyclomonomer B was
obtained in a single case (R ¼ Boc and n ¼ 2) as the minor RCM
product (Fig. 1). Nevertheless, the inhibition potential of the b-
lactam precursors A and RCM products C was tested against
R39, a low molecular weight D,D-peptidase5 which is commonly
used as a model of bacterial serine-enzymes. Compounds from
three families, differing in the nature of the N–C(3) substituent
(R ¼ Boc, Me, H) have been evaluated. The precursors A of theMed. Chem. Commun.
















































View OnlineN–H family (R]H) were good inhibitors of R39 and surpris-
ingly, the cyclodimersC of the N–H family were even more active
than their respective precursors, some of them showing a very
good inhibition potential. In order to study more deeply the
activity of this series of molecules, non-symmetrical precursors
and the corresponding dimers were synthesized, and evaluated
against R39, PBP2a and PBP5 (of Enterococcus faecium),
another example of a high-molecular-weight D,D-peptidase
responsible for bacterial resistance.6 Some bis-2-oxoazetidinyl
macrocycles showed promising activities against PBP2a. Non-
cyclic dimers were also synthesized to determine if the unique
activity of these compounds was due to the geometrical features
of the macrocycle or the presence of two b-lactam rings. The 3D
structures of all compounds have been studied by quantum
chemistry calculations. Molecule 5e was modelled as an acyl-
enzyme docked into the R39 and PBP2a active sites.Results
Synthesis
Starting from the chiron 1,4 i.e. (S)-3-(tert-butyloxycarbonyl)
amino-2-azetidinone, N(1) mono-acylated b-lactams 2a–c were
prepared regioselectively employing pyridine and alkenoyl
chlorides. The bis-acylated precursors 3a–i were then prepared inScheme 1 Synthesis of bis
Med. Chem. Commun.two steps. The Boc protecting group was removed in the presence
of trifluoroacetic acid and the resulting free amine function was
acylated with the appropriate alkenoyl chloride using triethyl-
amine as base (Scheme 1). Mono- (2) and bis-acylated products
(3) were isolated in high yields after chromatography.
Among the symmetrical precursors (n ¼ m ¼ 0, 1, 2), 3a could
not be cyclized (24-membered cyclic dimer not accessible), while
ring closing metathesis (RCM) reaction performed on 3e and 3i
under standard conditions (CH2Cl2, 40
C, 5 mM) in the pres-
ence of second generation Grubbs’ catalyst (2  5 mol%),
afforded 28-membered (4e) and 32-membered (4i) cyclic dimers
(probably mixtures of head–head (HH) and head–tail (HT)
regioisomers) in modest yields (35% and 28%, respectively). As
previously reported,4 ab initio calculations have suggested the
presence of intramolecular H bonds in these cyclic dimers,
stabilizing particular conformations of the macrocycle that could
explain why the cyclic dimers with R s H (i.e. R ¼ Boc, Me)
were not as good inhibitors of R39 D,D-peptidase as the N–H
derivatives. In order to study the possible influence on the bio-
logical activity of the length of the two branches of the cyclic
dimers, all the non-symmetrical dimers were similarly prepared.
Thus the RCM reaction of 3b, 3c, 3d, 3f, 3g and 3h led respec-
tively to the macrocycles 4b (26-membered), 4c (28-membered),
4d (26-membered), 4f (30-membered), 4g (28-membered), and 4h
(30-membered), with yields ranging from 31% to 57% (Scheme 2).-acylated precursors 3.
This journal is ª The Royal Society of Chemistry 2011
















































View OnlineThen the dimers were submitted to catalytic hydrogenation in the
presence of Pd/C to afford the corresponding saturated macro-
cycles 5b–i (Scheme 2).
Two non-cyclic dimers were considered as reference
compounds for comparison of the biochemical results. Their
precursors 6 and 9, structurally related to the b-lactam 3cScheme 3 Non-c
This journal is ª The Royal Society of Chemistry 2011(n ¼ 0 and m ¼ 2) were prepared by using the same sequence of
reactions as depicted before in Scheme 1. Starting from the
mono-acylated compound 2a, the Boc protecting group was
removed and the amine function was acylated with heptanoyl
chloride and triethylamine giving the bis-acylated b-lactam 6 in
80% yield. Mono-acylation of the chiron 1 in the presence of
pyridine and valeroyl chloride (40% yield), followed by Boc
deprotection and amine function acylation with hept-6-enoyl
chloride and triethylamine afforded 9 in 86% yield. Cross
metathesis of precursors 6 and 9 gave the respective non-cyclic
dimers 7 and 10 in good yields, and catalytic hydrogenation led
to the corresponding saturated products 8 and 11 (Scheme 3).
The accurate structural analysis of the RCM products 4 is
a very difficult task due to the presence of non-separable isomers:
(i) head–head (HH) and head–tail (HT) regioisomers, (ii) E and
Z stereoisomers because of the uncontrolled configuration of the
C]C double bonds. Additionally, the presence of conformers
makes the NMR analyses quite complicated (see Experimental
section in the ESI†). Using mass spectroscopy, we could observe
in some cases contamination products issued from double bond
migration (in precursors) leading in fine to dimers 4 with the
formal extrusion of one CH2 unit. To avoid this contamination
we performed the RCM reactions in the presence of 1,4-benzo-
quinone,7 but without achieving the complete disappearance of
the lower homologues.Inhibition of R39, PBP2a and PBP5
All bis-acylated b-lactams, precursors (i.e. 3, 6 and 9) and dimers
(i.e. 4, 5, 7, 8, 10 and 11), were evaluated for their potential
inhibition effect on bacterial serine enzymes.
The D,D-peptidase from Actinomadura R39 (ref. 5) is usually
considered for a preliminary screening of penicillin-like
compounds. R39 and the tested azetidinone (100 mM) were
incubated together (1 h, 25 C). After preincubation the residual
activity (RA) of the enzyme was determined by measuring the
hydrolysis rate of the thiolester substrate S2d (i.e. N-benzoyl-D-
alanyl-thioglycolate),8 in the presence of Ellman’s reagent (for
labeling the formed thiol), by monitoring the increase of absor-
bance at 412 nm. The results are given in Table 1 as percentages
(%) of residual activity. The activity in the absence of an inhibitoryclic dimers.
Med. Chem. Commun.




Cycle sizeRA (%) RA (%) RA (%)
1 3a >100 79 72
2 3b 14  3 93 98
3 3c 14  11 89 91
4 3d 39  12 100 99
5 3e 17  9 100 90
6 3f 21  27 85 74
7 3g 50  3 77 72
8 3h 15  3 82 86
9 3i 23  0 81 80
10 4b 2  1 92 91 26
11 4c 3  1 95 73 28
12 4d 9  1 86 84 26
13 4e 4  8 90 94 28
14 4f 1  2 98 78 30
15 4g 2  2 96 100 28
16 4h 3  1 100 100 30
17 4i 0 89 84 32
18 5b 2  1 70 70 26
19 5c 0 100 29 28
20 5d 0 100 55 26
21 5e 2 90 70 28
22 5f 1  1 100 22 30
23 5g 0  3 100 33 28
24 5h 2  1 72 63 30
25 5i 0 95 61 32
26 6 6  0 100 92
27 7 0 100 100
28 8 10  4 99 74
29 9 5  2 100 97
30 10 5  2 89 90
31 11 3  4 90 89
Fig. 2 Conformations (i), (ii), (iii) and (iv) of the precursors.
Table 2 Relative energies of the precursors in the selected
conformations
Compound
Relative energy of open precursors/kcal mol1
(i) (ii) (iii) (iv)
3a 4.73 5.50 0.00 0.33
3b 4.61 6.84 0.00 1.52
3c 4.71 5.64 0.00 0.40
3d 5.11 5.60 0.00 0.10
3e 4.82 6.27 0.00 0.91
3f 4.62 5.64 0.00 0.13
3g 4.80 5.51 0.00 0.07
3h 4.57 5.53 0.00 0.13
















































View Onlineis set at 100% and therefore low values indicate very active
compounds, since the enzyme has been inhibited by the tested
compound and consequently cannot hydrolyze its substrate. A
tested compound is considered as a ‘‘hit’’ (i.e. potential inhibitor
of interest) for a RA value below 80%.
Except one product amongst the precursors (entry 1, i.e.
compound 3a), all the other precursors and dimers inhibited
R39, and the dimers were generally more active than their
precursors.
Then all the compounds were evaluated against two high-
molecular-weight D,D-peptidases responsible for bacterial resis-
tance to b-lactam antibiotics: PBP2a from S. aureus and PBP5
from E. faecium.
PBPs and the tested azetidinone (1 mM) were incubated
together (4 h, 30 C). Then fluorescein-labelled ampicillin9 was
added to detect the residual activity (RA). In this protocol, the
tested compounds were supposed to be capable of acylating the
PBPs (to give stable acyl-enzyme intermediates), and the residual
activity of PBPs is determined by the amount of covalent PBP–
ampicillin complexes formed, as measured by fluorescence
spectroscopy after denaturation and SDS-PAGE separation of
the acylated enzymes from the reagent band.
Only a small activity against PBP5 was detected for two
precursors (entries 1 and 7) and two saturated cyclic dimers
(entries 18 and 24). Several products exhibited a small to
moderate activity against PBP2a (entries 1, 6, 7, 9, 11, 14, 18, 20,
21, 24, 25 and 28) but amongst the hydrogenated non-Med. Chem. Commun.symmetrical cyclic dimers, three compounds, namely 5c, 5f and
5g (entries 19, 22 and 23), showed a very good inhibition
potential.
None of the non-cyclic dimers had a significant activity on
PBP2a, therefore the activity could not be correlated simply to
the presence of two b-lactam rings. We hypothesized that
geometrical factors imposed by the macrocycles should be the
determining factors.Computational chemistry
The geometry of all the molecules has been fully optimized at the
B3LYP level10 using the 6-31G(d) basis set.11 A great number of
local minima could be trapped for precursors 3. Four confor-
mations of the precursors referred to as (i), (ii), (iii), and (iv) have
been located (Fig. 2). The C(3) amide function exhibits the trans
geometry in all cases;4 the conformers result from rotations
around the C(3)–N and N(1)–CO bonds. The four conforma-
tions lie in the same range of stability, the relative energies being
less than 7 kcal mol1; the (iii) conformation is always the most
stable one (Table 2) (all absolute energies of the precursors in the
selected conformations are given in the ESI†).
A lot of conformers can exist for the dimers 4 (only the trans
C]C configuration has been considered). Two conformations of
the b-lactam can be located giving rise to a head–head (HH) orThis journal is ª The Royal Society of Chemistry 2011























4b 0.00 1.13 5.30 6.43 5b 0.00 6.93
4c 14.00 14.24 0.00 0.24 5c 8.61 0.00
4d 19.06 17.65 0.00 1.40 5d 12.39 0.00
4e 9.59 3.93 0.00 5.66 5e 8.70 0.00
4f 0.00 2.32 7.36 9.68 5f 0.00 8.26
4g 14.21 17.22 0.00 3.01 5g 14.62 0.00
4h 0.00 11.08 1.85 12.93 5h 0.00 0.43
















































View Onlinehead–tail (HT) arrangement in the macrocycle. There are as
many stable HT conformers (i.e. 4c, 4d, 4e, 4g) as stable HH
conformers (i.e. 4b, 4f, 4h, 4i).
The heats of formation of the dimers have been calculated with
respect to the most stable conformation of their respective open
precursor which is the (iii) conformation (Table 3) (all absolute
energies of the HH and HT conformers are given in the ESI†).
The heat of formation of the most stable conformers is negative
or slightly positive.
For saturated compounds 5 (Table 3), the conformations often
remain in the same local minima as for the unsaturated ones and
their relative energies are slightly modified.Docking
All the cyclodimers display high activities against R39, while
some saturated cyclodimers have good activities against PBP2a.
So we focused on the saturated cyclodimers 5 to understand their
activities.
The molecule 5e has been docked as an acyl-enzyme complex
in the R39 (Fig. 3a) and PBP2a (Fig. 3b) cavities. This
symmetrical cyclodimer, featuring a medium activity against
PBP2a, has been selected as a representative compound of the
whole series 5.
Using the crystal structures of complexes of R39 and PBP2a3c
with b-lactam antibiotics as templates, 5e was docked into their
respective active sites, conserving the main interactions found inFig. 3 (a) Acyl-enzyme complex between 5e and R39. (b) Acyl-enzyme
complex between 5e and PBP2a. Legend: residues surrounding the alkyl
chain of the macrocycle in the bottom of the active site are highlighted
with carbon atoms coloured green, nitrogen blue and oxygen red. The
carbon atoms of 5e are coloured yellow and hydrogen white. The active
serine is hidden by the ligand.
This journal is ª The Royal Society of Chemistry 2011the X-ray structures. The HH conformer has been considered,
according to the reactivity model (see below). As expected, 5e
adapted perfectly to the geometrical constraints of the R39 cavity
(RA of 5e versusR39¼ 2%). The acyl-enzyme model showed that
the alkyl chain of the macrocycle can run into a mainly hydro-
phobic cavity that normally receives the side chain of the D-a-
aminopimelic acid, one of the amino acids constituting the
pentapeptide substrate. Consistent with the measured activity
(RA ¼ 70% versus PBP2a), 5e fitted quite well into the PBP2a
cavity although the cavity is narrower than in R39 (Fig. 3). The
residues of PBP2a surrounding the alkyl chain of the macrocycle
are not hydrophobic. The flexibility of the macrocycle 5f, the
most active non-symmetrical dimer versus PBP2a, allowed the
docking of both HH and HT isomers in the active site as acyl-
enzymes. The docking in the PBP2a active site highlighted the
possibility for the whole macrocycle to completely fill the cavity
with the closed lactam cycle sandwiched between Tyr446 and
Met641. (The figures of macrocycle 5f of both HH and HT
isomers docked as an acyl-enzyme complex in the PBP2a cavity
are given in the ESI†.)
The explanation of the difference between non-resistant and
penicillin-resistant PBP activity remains an open question. The
main feature could be related to the access to the nucleophilic
serine of resistant PBPs which is more ploughed in than the R39
one. So we hypothesized that the conformational flexibility of the
bis-2-oxoazetidinyl macrocycles could favor their insertion into
the ‘‘closed’’ conformation of PBP2a.
The significant differences in the biological results between
unsaturated (4) and the corresponding saturated macrocycles (5)
could also be due to conformational features.Reactivity
To go a step further, the potential acylating power of the bis-2-
oxoazetidinyl macrocycle 5e (HH dimer) has been estimated by
computational chemistry. The reaction considered is the
concerted b-lactam ring opening by nucleophilic attack of the
active serine residue. The location of the transition state (TS)
structure has been performed with an elaborated model of the
R39 active site representing the three conserved motifs of the
PBP family, as reported from the X-ray data.5 The first motif is
composed of the nucleophilic serine Ser49 and the following
amino acids Asn50, Met51 and Lys52. The second and third
motifs are formed by Ser298, Asn299 and Asn300, and Lys410,
Thr411, Gly412 and Thr413, respectively.12 The TS structure hasMed. Chem. Commun.
Fig. 4 Compound 5e at the transition state in the model of the R39
active site. Legend: C of 5e are in purple, others are in yellow, H are in
grey, O are in red, N are in blue, and hydrogen bonds are shown as thin
sticks.
Fig. 5 Representative conformers of 5c, 5f and 5g. Relative energies are
















































View Onlinebeen fully optimized in all the directions given by the degrees of
freedom at the RHF/MINI-10 level13 (216 atoms, 632 basis
functions) (Fig. 4). (The stereo view corresponding to Fig. 4 is
given in the ESI†.) At this equilibrium structure, Ser49, Lys52
and Ser298 side-chains form a pseudo-8-membered ring with the
C(2)–N(1) bond of one b-lactam ring in order to transfer the Og
hydrogen to the b-lactam N(1) via the Lys amino group.
Similarly to the docking, to be well orientated into the model
(and hence into the active site), the carbonyl of the amide on
position C(3)–N has to rise below the 4-membered ring and the
acyl chain of the macrocycle has to expand to the right upper
corner C(4) of the processed b-lactam. This precise type of
conformation of one b-lactam ring has been chosen for the
representation of compounds 5c, 5f and 5g depicted in Fig. 5 (all
figures of compounds 4b–i and 5b, 5d–i are given in the ESI†).
This type of arrangement was the one used for the docking of
compound 5e.
Depending on the size of the cycle growing from 26 to 32
bonds, the ‘‘pitch of screw’’ has a great influence on the confor-
mation either in the HH or the HT arrangement. For some
molecules, a conformation where the acyl chain of the macro-
cycle is more orientated towards the carbonyl C(2) of one b-
lactam ring, is localized for 4/5c, 4/5d and 4/5e HT geometries.
This could be related to the inadequacy of this conformation to
accommodate the active site. The molecules 4/5c, 4/5e and 4/5g
containing the same number of methylene units (28-membered
ring) are interesting as they can adopt an active-site compatible
geometry in their HH arrangement (Fig. 5 and 6). In the case of
4/5i (32-membered ring), the conformation looks the same in HH
and HT arrangements. All the optimized geometries are local
minima. What is remarkable is the ability of some molecules to
adapt their conformation to the active site. An example is
detailed with compound 5e. The HT geometry is the most stable
with regard to the HH(1) one which is 8.70 kcal less stable. A
modification of the geometry has been applied to dock this
molecule into R39 as well for the localisation of the TS structure
in the theoretical model. Starting from these two differentMed. Chem. Commun.geometries, a reoptimization at the B3LYP/6-31G(d) level leads
to two other local minima HH(2) (from docking) and HH(3)
(from the theoretical model) with relative energies of 9.51 kcal
and 14.73 kcal (Fig. 6). The biological results could be related to
the conformational adaptability of the compounds which is
a tenuous equilibrium between the size of the cycle and the
geometric constraints imposed by its conformation.Discussion
All the dimers 4/5 exhibit a high activity against a non-resistant
PBP (R39) and solely some saturated cyclodimers 5 show a good
activity against a resistant PBP (PBP2a). The fine analysis of the
behaviour of the bis-2-oxoazetidinyl macrocycles 4/5 is
a problem of huge complexity, for a lot of reasons. The RCMThis journal is ª The Royal Society of Chemistry 2011
















































View Onlinereaction affords most probably a distribution of HH and HT
regioisomers, as well as mixtures of E/Z olefins. For the hydro-
genated compounds 5 the problem of E/Z geometry has been
suppressed, but there are still HH and HT isomers for which the
distribution product is not known. For each regioisomer, several
conformations exist. The conformers are more or less stabilized
and present different geometrical constraints due to the presence
in the cyclodimers of intramolecular H bonds. Proton NMR
experiments were performed in order to determine if the amide
protons of cyclic dimers were involved in intramolecular H-
bonding. One amide proton of 5c exhibited a different behaviour
compared to the non-cyclic dimer 11, which supported the
involvement of one intramolecular hydrogen bond in the cyclic
dimer (results are given in the ESI†).
Using a model of the R39 active site, we have determined the
geometrical requirements necessary to form the transition state
of the acyl-enzyme complex: (i) the macrocyclic chain has to
expand to the right upper corner C(4) of the processed b-lactam;
(ii) the carbonyl of the amide on position C(3)–N has to rise
below the b-lactam ring to allow the interaction with the NH of
the Asn300 amino acid residue.
This model of reactivity could also be applied to the case of
PBP2a that shares with R39 the same three conserved motifs in
the catalytic cavity. The differences are to be found at the entry
and at the bottom of the respective cavities.3,5 Globally, the
active serine of PBP2a is less accessible, because it is more buried
into the active site.
Amongst the saturated cyclodimers 5, because of the intra-
molecular H bonds, compounds are more or less distorted and
some of them look like a screw. This structural feature is moreThis journal is ª The Royal Society of Chemistry 2011pronounced for the non-symmetrical dimers compared to the
symmetrical ones of the same size. As a matter of fact, the best
activities were recruited for the ‘‘non-symmetrical’’ compounds
(5c, 5d, 5f, and 5g).
The poor activity (or the absence of activity) of all the dimers
4/5 against PBP5 could not be rationalized. Ceftobiprole,
a cephalosporin derivative with high affinity for PBP2a of
MRSA, is not similarly active against PBP5 of E. faecium. The
role of the antibiotic side-chains (at positions 7 on the b-lactam
ring and 3 on the fused six-membered ring) on their specificity is
not yet elucidated.14 These chains are supposed to contribute to
the good positioning of the b-lactam carbonyl versus the active
serine of the target PBP. In particular, the different chains fixed
on the cephalosporin fused ring (ceftobiprole and ceftazidime,
for example) could behave as a ‘‘lever arm’’ inducing an unpre-
dictable inhibition pattern against the set of PBPs.15 So, it is not
surprising that our compounds show different affinities for
PBP2a and PBP5.Conclusion
Currently, the mode of action of non-resistant and resistant
PBPs, at the molecular level, is not fully understood. The
comprehension of molecular interactions between proteins and
small molecules relies on complementary studies based on
experimental (measured activities, X-ray structures) and theo-
retical data (modeling, docking experiments), making the foun-
dation of structure-based drug design.16
Herein we have disclosed a novel family of b-lactam
compounds capable of acylating PBPs, namely the bis-2-oxoa-
zetidinyl macrocycles. 26- to 32-Membered bis-2-oxoazetidinyl
macrocycles devoid of side-chain (R]H) are synthesized using
the RCM reaction as the key-step for cyclodimerization. All the
compounds are good inhibitors of R39; some saturated macro-
cycles reveal very promising activities against PBP2a of MRSA
while the corresponding linear dimers are inactive confirming
that the activity is not imputable to the presence of two b-lactam
cores in the molecules. The structure of our novel inhibitors is
totally different from that of penicillins or cephalosporins, and
abolishes the traditional dogma linked to the b-lactam antibi-
otics, such as the requirement of a 5- or 6-membered cycle fused
to the N(1)–C(4) atoms of the b-lactam ring, and the presence of
a carboxylic function on this fused ring.
Geometrical and conformational factors have been identified
to be responsible for the activity of all compounds against R39 D,
D-peptidase, and of some compounds against PBP2a from
MRSA. The activity of lipophilic b-lactams (such as 4 and 5)
could be related to the specificity of PBP2a which processes only
cell-wall precursors bearing a pentaglycine strand attached to
a lysine residue of the stem peptide.17 The bis-2-oxoazetidinyl
macrocycles which feature branches of different lengths for
connecting the two four-membered rings are the most active ones
against PBP2a (i.e. compounds 5c, 5d, 5f, 5g). Due to the
occurrence of intramolecular H-bonds inducing geometrical
constraints, the so-called non-symmetrical dimers 5 look like
screws. Their pitch of screw, depending on the macrocycle size
with the optimum for 28-membered cycles, combined with their
high conformational adaptability could probably explain why,
















































View Onlineslip in, and to adapt to the closed conformation of the PBP2a
active site. In the context of the urgent need of new antimicrobial
agents with activity against MRSA and other resistant patho-
gens, our work provides an alternative approach for the rational
design of active b-lactams.Acknowledgements
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